Foreign Corrupt Practices Act Raises Disclosure Dilemma For Internal Investigations
Executive Summary
While companies are feeling pressure to voluntarily disclose potential violations of the Foreign Corrupt Practices Act, it may not always be the most prudent action, former government attorneys suggested at a recent meeting.
You may also be interested in...
DoJ Bull’s Eye: Off-Label Promotion, Formulary Placements, FCPA Violations Remain Targets
A Pfizer attorney says government saber rattling over individual liability does not mean there will be a spike in individual prosecutions; Pfizer’s cooperation with the government helped it avoid criminal resolution in a Foreign Corrupt Practices Act settlement.
How To Resolve A Foreign Corrupt Practices Act Probe: Reveal Info About Your Company And Your Competitors
A Department of Justice official says disclosing information about competitors' behavior can help slash the penalty for bribery, as J&J accomplished in its settlement.
J&J Takes The Lead In Settling SEC/DoJ Foreign Corrupt Practices Act Probe
The government charged J&J with bribing doctors in Greece, Poland and Romania to order or prescribe its products; the $70 million settlement includes a deferred prosecution agreement.